Literature DB >> 3050163

Assessing hospital-associated deaths from discharge data. The role of length of stay and comorbidities.

S F Jencks1, D K Williams, T L Kay.   

Abstract

To assess the meaning of hospital-associated death rates, we studied whether mortality within 30 days of hospital admission (30-day mortality) is more informative than inpatient mortality and whether detailed assessment of additional discharge diagnoses helps in understanding death rates. We examined hospitalizations for elderly Medicare patients with principal diagnoses of stroke, bacterial pneumonia, myocardial infarction, and congestive heart failure; these conditions account for 30.8% of Medicare 30-day mortality. Average hospital stays for these conditions were 99.0% longer, and inpatient mortality was 25.0% higher in New York than in California, but 30-day mortality was 1.6% higher in California. We conclude that inpatient death rates depend on length-of-stay patterns and give a biased picture of mortality. Additional diagnoses such as shock and pneumonia were strongly associated with increased mortality, but Medicare data do not reveal which patients had these conditions at the time of admission. Recorded diagnoses of chronic diseases such as hypertension, diabetes mellitus, obesity, benign prostatic hypertrophy, and osteoarthritis were commonly associated with reduced risk of death; such reduced risk is not clinically plausible. Several lines of evidence suggest that chronic disorders are underreported for patients with life-threatening disorders. We recommend great caution in using discharge diagnoses of comorbid conditions to adjust hospital death rates for clinical differences in the patient populations.

Entities:  

Mesh:

Year:  1988        PMID: 3050163

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  85 in total

1.  Differences in death rates in English hospitals. Effects of admission rates may have been understated.

Authors:  T Hennell
Journal:  BMJ       Date:  1999-09-25

2.  Learning from differences within the NHS. Clinical indicators should be used to learn, not to judge.

Authors:  A G Mulley
Journal:  BMJ       Date:  1999-08-28

3.  Relationships between in-hospital and 30-day standardized hospital mortality: implications for profiling hospitals.

Authors:  G E Rosenthal; D W Baker; D G Norris; L E Way; D L Harper; R J Snow
Journal:  Health Serv Res       Date:  2000-03       Impact factor: 3.402

4.  Risk adjustment using administrative data: impact of a diagnosis-type indicator.

Authors:  W A Ghali; H Quan; R Brant
Journal:  J Gen Intern Med       Date:  2001-08       Impact factor: 5.128

5.  Development of a prognostic model for six-month mortality in older adults with declining health.

Authors:  Paul K J Han; Minjung Lee; Bryce B Reeve; Angela B Mariotto; Zhuoqiao Wang; Ron D Hays; K Robin Yabroff; Marie Topor; Eric J Feuer
Journal:  J Pain Symptom Manage       Date:  2011-11-08       Impact factor: 3.612

Review 6.  The evolving science of quality measurement for hospitals: implications for studies of competition and consolidation.

Authors:  Patrick S Romano; Ryan Mutter
Journal:  Int J Health Care Finance Econ       Date:  2004-06

7.  Overcoming potential pitfalls in the use of Medicare data for epidemiologic research.

Authors:  E S Fisher; J A Baron; D J Malenka; J Barrett; T A Bubolz
Journal:  Am J Public Health       Date:  1990-12       Impact factor: 9.308

8.  The implications of long-term acute care hospital transfer practices for measures of in-hospital mortality and length of stay.

Authors:  William B Hall; Laura E Willis; Sofia Medvedev; Shannon S Carson
Journal:  Am J Respir Crit Care Med       Date:  2012-01-01       Impact factor: 21.405

9.  Routine data: a resource for clinical audit?

Authors:  M McKee
Journal:  Qual Health Care       Date:  1993-06

10.  Using severity measures to predict the likelihood of death for pneumonia inpatients.

Authors:  L I Iezzoni; M Shwartz; A S Ash; Y D Mackiernan
Journal:  J Gen Intern Med       Date:  1996-01       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.